The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]


Variant: NM_000261.2(MYOC):c.1309T>C (p.Tyr437His)

CA119169

7946 (ClinVar)

Gene: MYOC
Condition: juvenile open angle glaucoma
Inheritance Mode: Autosomal dominant inheritance
UUID: 49b3b4bf-7c55-4a5d-b01c-2c1d71639162

HGVS expressions

NM_000261.2:c.1309T>C
NM_000261.2(MYOC):c.1309T>C (p.Tyr437His)
NC_000001.11:g.171636131A>G
CM000663.2:g.171636131A>G
NC_000001.10:g.171605271A>G
CM000663.1:g.171605271A>G
NC_000001.9:g.169871894A>G
NG_008859.1:g.21503T>C
ENST00000037502.11:c.1309T>C
ENST00000637303.1:c.235-2499A>G
ENST00000638471.1:c.*647T>C
ENST00000037502.10:c.1309T>C
ENST00000614688.1:c.*273T>C
NM_000261.1:c.1309T>C

Pathogenic

Met criteria codes 5
PP1_Strong PS4_Moderate PM2_Supporting PP3 PS3_Moderate
Not Met criteria codes 10
BA1 BS3 BS1 BP4 BP7 PS2 PS1 PM6 PM5 PM4

Evidence Links 3

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen Glaucoma Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines Version 1.1

PDF
Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
Glaucoma VCEP
The c.1309T>C variant in MYOC is a missense variant predicted to cause substitution of Tyrosine by Histidine at amino acid 437 (p.Tyr437His). This variant was not found in any population of gnomAD (v2.1.1), meeting the ≤ 0.0001 threshold set for PM2_Supporting in a population of at least 10,000 alleles. The REVEL score = 0.966, which met the ≥ 0.7 threshold for PP3, predicting a damaging effect on MYOC function. Previous studies (PMIDs: 16466712 and 35196929) demonstrated that the Tyr437His protein had increased insolubility and reduced secretion levels compared to wild type myocilin protein and met the OddsPath threshold for PS3_Moderate (> 4.3), indicating that this variant did impact protein function. 39 segregations in 3 families, with juvenile or primary open angle glaucoma (JOAG or POAG), have been reported (PMIDs: 9535666, 30612094), which fulfilled PP1_Strong (≥ 7 meioses in > 1 family). 6 probands with JOAG or POAG have been reported carrying this variant (PMIDs: 10196380, 9792882, 30612094), which met PS4_Moderate (≥ 6 probands). In summary, this variant met the criteria to receive a score of 10 and to be classified as pathogenic (pathogenic classification ≥ 10) for juvenile open angle glaucoma based on the ACMG/AMP criteria met, as specified by the ClinGen Glaucoma VCEP (v1, 12 Oct 2021): PP1_Strong, PS3_Moderate, PS4_Moderate, PP3, PM2_Supporting.
Met criteria codes
PP1_Strong
39 segregations in 3 families, with juvenile or primary open angle glaucoma (JOAG or POAG), have been reported (PMIDs: 9535666, 30612094), which fulfilled PP1_Strong (≥ 7 meioses in > 1 family).
PS4_Moderate
6 probands with JOAG or POAG have been reported carrying this variant (PMIDs: 10196380, 9792882, 30612094), which met PS4_Moderate (≥ 6 probands).
PM2_Supporting
This variant was not found in any population of gnomAD (v2.1.1), meeting the ≤ 0.0001 threshold set for PM2_Supporting in a population of at least 10,000 alleles.
PP3
The REVEL score = 0.966, which met the ≥ 0.7 threshold for PP3, predicting a damaging effect on MYOC function.
PS3_Moderate
Previous studies (PMIDs: 16466712 and 35196929) demonstrated that the Tyr437His protein had increased insolubility and reduced secretion levels compared to wild type myocilin protein and met the OddsPath threshold for PS3_Moderate (> 4.3), indicating that this variant did impact protein function.

Not Met criteria codes
BA1
This criterion was not met as PM2_Supporting has been met.
BS3
This criterion was not met as PS3_Moderate has been met.
BS1
This criterion was not met as PM2_Supporting has been met.
BP4
This criterion was not met as PP3 has been met.
BP7
This is not a synonymous or non-coding variant.
PS2
This variant has not been identified de novo.
PS1
An established pathogenic variant causing this same amino acid change has not been identified.
PM6
This variant has not been identified de novo.
PM5
No other missense variants at this amino acid residue have been identified.
PM4
This variant does not cause a protein length change.
Approved on: 2022-03-07
Published on: 2022-07-11
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.